Abstract
Background: The authors challenged the current pain treatment paradigm and its focus on the systemic treatment of pain by the oral administration of opioids, high dose non-steroid anti-inflammatory drugs, anticonvulsants, and psychotropic drugs and studied and retrospectively analyzed the efficacy of a transdermal emulsion on various chronic pain conditions. Case Reports: The clinician has an active chronic and acute pain practice and favors transdermal drug treatment for various pain conditions. The therapy consisted of a transdermal emulsion containing gabapentin and naproxen sodium in a 10% to 5% ratio. The treatment included 2-3/day application of emulsion to the target area. Substantial pain relief was obtained in the treatment of chronic and acute myofascial, musculoskeletal, and neuropathic pain. Conclusion: The authors offer transdermal combination drug therapy as an appropriate peripheral pain treatment alternative to systemic drug therapy and avoid the human and societal costs of opioids, high dose NSAIDs and psychoactive drugs.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
